Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MULTI-CENTER,DOUBLE-BLIND, RANDOMIZED, TWO-ARMS, CONTROLLED, PROSPECTIVE CLINICAL INVESTIGATION ASSESSING THE SAFETY AND PERFORMANCE OF A CLASS IIb MEDICAL DEVICE (CLEARPLASMATM) FOR THE TREATMENT OF PATIENTS WITH ACUTE UPPER GASTROINTESTINAL HEMORRHAGE.

NCT04174989 is registered in ClinicalTrials.gov with PlasFree Ltd. as lead sponsor.

NCT NCT04174989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04174989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MULTI-CENTER,DOUBLE-BLIND, RANDOMIZED, TWO-ARMS, CONTROLLED, PROSPECTIVE CLINICAL INVESTIGATION ASSESSING THE SAFETY AND PERFORMANCE OF A CLASS IIb MEDICAL DEVICE (CLEARPLASMATM) FOR THE TREATMENT OF PATIENTS WITH ACUTE UPPER GASTROINTESTINAL HEMORRHAGE.
Lead sponsor
PlasFree Ltd.
Phase
Not applicable
Overall status
Completed
Start date
October 24, 2020
Completion date
November 13, 2022
Enrollment
53 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute upper gastrointestinal bleeding, acute upper gastrointestinal hemorrhage